Jill Howe Email

Chief Financial Officer . Lineage Cell Therapeutics

Carlsbad , CA

Location

Current Roles

Employees:
37
Revenue:
$5M
About
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.
Lineage Cell Therapeutics Address
2173 Salk Avenue
Carlsbad , CA
United States
Lineage Cell Therapeutics Email
Lineage Cell Therapeutics Phone Numbers
442-287-8963

Past Companies

Lineage Cell TherapeuticsChief Financial Officer
Biora TherapeuticsMember Board Of Directors
Codagenix Inc.Member Board Of Directors

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.